Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 21, 2019
Hutch CIO gives keynote at Hopperx1 women-in-tech conference
Kathy Alexion spoke about cloud computing's potential to accelerate cancer research
Highlights of Fred Hutch science in 2018
A look back at notable advances in immunotherapy, precision screening and more
Fred Hutch collaborates with new Allen Institute for Immunology
Multi-collaborator initiative aims to map the immune system in health and disease
Hutch Holiday Gala raises $10.4M to fuel cancer research at intersection of innovation
Data science, technology and life sciences come together to accelerate cancer cures
Drs. Siddhartha Mukherjee and Gary Gilliland in conversation
Watch: Author and physician-scientist discusses the next chapters in cancer research — and his book ‘Emperor of all Maladies’ — with Hutch President and Director
Dr. Gary Gilliland a finalist for GeekWire’s Geek of the Year award
Hutch president and director among five 'Northwest heavy hitters working to do good using technology'
Data drives life sciences boom in Seattle
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
Finasteride can reduce prostate cancer risk long term
Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss
Big data in cancer research
New study in childhood leukemia illustrates challenges and power of cutting-edge genomic technologies’ huge data sets
‘Remarkable’ distinctions in pediatric leukemia point toward improved treatment
Big new study in pediatric and young adult acute myeloid leukemia warns against ‘trickle-down therapeutics’
Glioblastoma blasted into two types
From the Paddison Laboratory, Human Biology
Will the flu vaccine work for you? Answer may be in your genes
Set of 9 genes that predicts flu response in adults under 35 could be first step to personalized vaccine
Good News at Fred Hutch
Celebrating faculty and staff achievements
Vice President Joe Biden delivers 'Cancer Moonshot' recommendations
Top priority, catalyzing scientific breakthroughs, calls for interdisciplinary approaches to speed cures
Good News: Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response
Celebrating faculty and staff achievements
Microsoft CEO Satya Nadella and other tech, business leaders join Hutch board of trustees
<p>Board will help guide center in ‘achieving the most ambitious goals in cancer research’</p>
‘We can get this done’: National Cancer Moonshot takes flight
Moonshot Summit at Fred Hutch part of coast-to-coast conversation to stop cancer
Metastatic Breast Cancer Project uses social media to connect with patients, speed cures
The social media-powered, patient-driven Metastatic Breast Cancer Project aims to speed cures
Beyond immunotherapy: Xconomy forum covers breadth of Seattle’s life sciences scene
Xconomy forum highlights research in vaccines, organ transplants, big data, more
Future of big data depends on collaboration
Removing silos will open path to precision medicine